Clinical Edge Journal Scan

Higher dietary caffeine intake tied to severe headaches or migraines


 

Key clinical point: Higher intake of dietary caffeine was positively associated with a higher prevalence of severe headaches or migraines in US adults.

Major finding: Overall, the incidence of severe headaches or migraines increased by 5% with each 100 mg/day increase in dietary caffeine intake (odds ratio [OR] 1.05; P < .001), with the risk increasing by 42% with caffeine intake ≥ 400 mg/day vs ≥0 to <40 mg/day (OR 1.42; P < .001).

Study details: This cross-sectional study evaluated the association between dietary caffeine intake and severe headaches or migraines in 8993 U.S. adults age ≥ 20 years.

Disclosures: This study was funded by the Shandong Traditional Chinese Medicine Science and Technology Development Project, China. The authors declared no conflicts of interest.

Source: Zhang L et al. Association between dietary caffeine intake and severe headache or migraine in US adults. Sci Rep. 2023;13:10220 (Jun 23). Doi: 10.1038/s41598-023-36325-8

Recommended Reading

Prodrome treatment with ubrogepant prevents migraines
Migraine ICYMI
What is the proper treatment for posttraumatic headache? Expert debate
Migraine ICYMI
Commentary: Refractory chronic migraine treatment, July 2023
Migraine ICYMI
Migraine elevates risk for ischemic stroke in men and women with migraine
Migraine ICYMI
Study supports use of BP-lowering medications for prevention of episodic migraine
Migraine ICYMI
Potential moderators of response to behavioral treatment for migraine prophylaxis
Migraine ICYMI
Meta-analysis confirms benefits of rimegepant in episodic migraine
Migraine ICYMI
Decrease in visual hypersensitivity predicts clinical response to anti-CGRP mAbs in migraine
Migraine ICYMI
Ultrasound-guided stellate ganglion block: A safe and effective option for treating migraine in elderly
Migraine ICYMI
Long-term erenumab shows sustained efficacy and safety in chronic migraine
Migraine ICYMI